Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
DRUG ALERT
CLASS 2 MEDICINES RECALLPHARMACY OR EQUIVALENT LEVEL RECALL
| 06 November 2009 | EL (09)A/28Rev 1 | Our ref: MDR 71-10/09 |
Dear Healthcare Professional,
Abraxis BioScience Ltd
Abraxane 5mg/ml powder for suspension for infusion
Paclitaxel Albumin
| Batch Number | Expiry Date | Pack Size | First Distributed |
|
405693A |
12/2009 | Single 50 ml vials | 12/2008 |
The batch number quoted in yesterday's drug alert which was checked by the company has now been reported as incorrect. Please ignore the communication sent yesterday and replace it with this document. We apologise for the inconvenience you have experienced.
Abraxis BioScience Ltd are recalling all remaining stock of the above batch as a precautionary measure. Particulate matter has been found in other batches of Abraxane made in the same time period.
Medical Information enquiries should be telephoned to 0207 081 0850.
Please quarantine any remaining stocks of this batch. Recipients will be contacted by Aexxdis (the appointed distributor) and given instructions for stock returns. For any related enquiries, please telephone Aexxdis on 05603 141 956.
Supplies of the licensed UK presentation of Abraxane are not expected to return to normal until the end of Q1 2010.
Regional Contacts for NHS Trusts and Provider Units
Chief Pharmacists: England, Scotland, Wales, Northern Ireland
Prison Health Policy Unit (DH)
Chief Pharmacists: Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar
Special Hospitals
Healthcare Commission for distribution to Independent Health Care Establishments
Primary Care Trusts (England)
Class 2 Drug Alert (Action within 48 hours): Abraxis 5mg/ml powder for suspension for infusion - EL (09)A/28Rev 1 
